PCSK9 and fatty liver disease: In our study, we employed the proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function (GOF) model in conjunction with a high-fat diet [35,36,37], which has been demonstrated to induce atherosclerosis and fatty liver in mice without the necessity of genetic modification.